This report offers an update on the power of solid data analytics strategy and automated workflow solutions as scientists aim to break down the barriers to the ‘lab of the future’.
“By combining artificial intelligence (AI) and automatic collection of data at scale, pharma companies are able to accelerate their decision making processes and ensure that is based on the highest quality of information”.
Charles Fracchia, CEO of BioBright & VP of Data at Dotmatics
How to unlock the true value of data and meet the challenges of system integration
Where ROI of lab software can be evidenced and how to demonstrate value via data
Why managing changes in the lab environment can benefit efficiency and provide results
Sign Up to read the whitepaper